The 2024 Nobel prize in physiology or medicine goes to two researchers, Victor Ambros and Gary Ruvkun, for their work on ...

Researchers at the University of Sheffield have been awarded funding for their infectious disease technology that could make ...

Analysis - Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 million deaths from the disease. This makes COVID the ...

Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...

In the late 1980s, Ambros and Ruvkun were postdoctoral researchers in the laboratory of Robert Horvitz, who received the ...

The two companies brought legal action over a repeated sequence in the messenger RNA (mRNA) used in CureVac's patents in life ...

Moderna (MRNA) closed at $58.39 in the latest trading session, marking a -0.56% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.97%. Elsewhere, the Dow saw an ...

Triple-negative breast cancer (TNBC) is the subtype of breast cancer that is the hardest to treat. TNBC patients account for more than 20,000 cases of this condition annually in the U.S. alone.

Two scientists have won the Nobel Prize in physiology or medicine for their discovery of microRNA, tiny bits of genetic material that serve as on and off switches inside cells that help control what t ...

From horror novels for Halloween moods, romantasy books for cozy reading and sci-fi escapism for rainy daydreaming, these ...

Triple-negative breast cancer (TNBC) is the subtype of breast cancer that is the hardest to treat. TNBC patients account for ...

Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...